Defining Success in HS Treatment, Biological Selection, and Comorbidity Screening: A Conversation with Dr. Jennifer Hsiao
Dermatologists now have three approved biologics for the treatment of moderate-to-severe hidradenitis suppurativa (HS); bimekizumab…



